Searched for
FRESENIUS KABI INDIA
Fresenius Kabi gets 2 months extension for delisting offerFresenius Kabi Oncology today said Securities Appellate Tribunal (SAT) has granted it an extension of two months to complete its delisting ...- Indian drug manufacturing sites face USFDA's warning delugeThe US drug regulator has issued warning letters to Indian drugmakers Promed Exports and Posh Chemicals for violation of good manufacturing...
- Government clears 17 FDI proposals worth Rs 993 croreThe govt has approved 17 FDI proposals totalling Rs 992.61 cr, while recommending the Rs 2,058 cr Jet-Etihad deal for final clearance to Ca...
- Promoters want to delist Fresenius Kabi Oncology from boursesFresenius Kabi (Singapore) Pte Ltd is planning to delist its Indian arm Fresenius Kabi Oncology by buying out 19 % stake held by the public.
- Parenteral Drugs to sell unit to Fresenius Kabi for Rs 200 crParenteral Drugs today said its subsidiary, Goa Formulations has entered into an agreement with Fresenius Kabi India to sell its manufactur...
- Investors betting on delisting of MNC stocks may be in for a rude shockAfter Fresenius Kabi Oncology, Disa India is the latest multi-national company to launch an ‘offer for sale’ through stock exchanges to inc...
- Local arms of MNCs use 'offer for sale' route to increase public holding; investors stand to looseThere is bad news for investors who bought MNC stocks hoping to make a killing if the cos decide to delist shares to escape minimum public ...
- Fresenius Kabi to pay higher compensation to clinical trial victimsFresenius Kabi Oncology, the Indian arm of Germany's Fresenius Kabi will increase the compensation it paid to families of two volunteers wh...
- Delist hopeful Fresenius Kabi Oncology plunges 20% after company's share sale offerFresenius shares crashed 20% after its foreign parent's proposed offer for sale through stock exchanges to increase the public holding in t...
- Best of the market rally is over: SMC CapitalsIf you have not invested in a single rupee, you have to hope and pray for a dip and then probably enter, says Jagannadham Thunuguntla, SMC ...
- Fresenius Kabi's India unit now global R&D hubFresenius Kabi Oncology has restructured its business, making it one of the global R&D and manufacturing hubs for the German promoter.
- Dabur Pharma gets Government nod for name changeDabur Pharma on Tuesday said it has received the government's approval for changing its name to Fresenius Kabi Oncology.
- German owner taps options on Dabur Pharma delistingGerman company Fresenius Kabi, which recently acquired Dabur Pharma, is learnt to be exploring the possibility of delisting the company fro...
- Fresenius Kabi to invest 30 mn euros in Dabur’s API plantFresenius Kabi, which acquired the Burmans’ pharma business early this year, will invest around 30 euros million in the active pharmaceutic...
- Open offer to Dabur Pharma shareholders rescheduledDabur Pharma on Tuesday said the open offer to its shareholders by German firm Fresenius Kabi has been rescheduled and will now begin on Ju...
- Fresenius Kabi makes open offer to buy 20% of Dabur PharmaFresenius Kabi, an arm of German healthcare group Fresenius SE, on Wednesday made an open offer to buy an additional 20 per cent in Burman ...
- Fresenius Kabi to invest $70 mn, announces open offerDays after acquiring 73.3 per cent control of Dabur Pharma, European health care firm Fresenius Kabi on Monday said it would launch a publi...
- German co Fresenius Kabi picks up 73% in Dabur PharmaGerman co Fresenius Kabi acquired the stake in Dabur Pharma for around Rs 872 cr. With this, the Burman family exits pharmaceutical biz. Go...
- German firm Fresenius leads race for Dabur PharmaSources say that Fresenius Kabi is in advanced talks with the Indian company and has valued Dabur Pharma at over Rs 1,000 cr. Corporate Ind...
- Fresenius Kabi to expand product portfolio in IndiaFresenius Kabi plans to expand its product portfolio in India in next one year and is awaiting approval for the same from the regulators.
Load More- Promoters want to delist Fresenius Kabi Oncology from bourses
